Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F R Appelbaum

Showing results (221-230 of 490) with videos related to

Pageof 49
Sort By:
Blood|September 1, 1993
Long-term follow-up of patients with invasive fungal disease who received adjunctive therapy with recombinant human macrophage colony-stimulating factorJ Nemunaitis, K Shannon-Dorcy, F R Appelbaum, et al.
Blood|January 1, 1993
Effects of recombinant canine stem cell factor, a c-kit ligand, and recombinant granulocyte colony-stimulating factor on hematopoietic recovery after otherwise lethal total body irradiationF G Schuening, F R Appelbaum, H J Deeg, et al.
Human Gene Therapy|December 1, 1994
Study on contribution of genetically marked peripheral blood repopulating cells to hematopoietic reconstitution after transplantationF Schuening, A D Miller, B Torok-Storb, et al.
Transplantation|March 1, 1993
What role for 15-deoxyspergualin in enhancing engraftment of unrelated, histoincompatible canine marrow grafts and preventing graft-versus-host disease?R F Raff, R Storb, T Graham, et al.
Blood|September 1, 1981
Treatment of non-Hodgkin's lymphoma with marrow transplantation in identical twinsF R Appelbaum, A Fefer, M A Cheever, et al.
Bone Marrow Transplantation|March 1, 1993
Consequences of cryopreserving first remission autologous marrow for use after relapse in patients with acute myeloid leukemiaK Schiffman, R Clift, F R Appelbaum, et al.
Blood|April 15, 1993
A prospective randomized comparison of total body irradiation-etoposide versus busulfan-cyclophosphamide as preparatory regimens for bone marrow transplantation in patients with leukemia who were not in first remission: a Southwest Oncology Group studyK G Blume, K J Kopecky, J P Henslee-Downey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Conditioning regimen-dependent disposition of cyclophosphamide and hydroxycyclophosphamide in human marrow transplantation patientsJ T Slattery, T F Kalhorn, G B McDonald, et al.
Bone Marrow Transplantation|September 1, 1996
Syngeneic marrow transplantation in patients with multiple myelomaW I Bensinger, T Demirer, C D Buckner, et al.
Blood|June 1, 1994
Cyclophosphamide plus ATG conditioning is insufficient for sustained hematopoietic reconstitution in patients with severe aplastic anemia transplanted with marrow from HLA-A, B, DRB matched unrelated donorsH J Deeg, C Anasetti, E Petersdorf, et al.
Pageof 49

Showing results (221-230 of 490) with videos related to

Sort By:
Pageof 49
Blood|September 1, 1993
Long-term follow-up of patients with invasive fungal disease who received adjunctive therapy with recombinant human macrophage colony-stimulating factorJ Nemunaitis, K Shannon-Dorcy, F R Appelbaum, et al.
Blood|January 1, 1993
Effects of recombinant canine stem cell factor, a c-kit ligand, and recombinant granulocyte colony-stimulating factor on hematopoietic recovery after otherwise lethal total body irradiationF G Schuening, F R Appelbaum, H J Deeg, et al.
Human Gene Therapy|December 1, 1994
Study on contribution of genetically marked peripheral blood repopulating cells to hematopoietic reconstitution after transplantationF Schuening, A D Miller, B Torok-Storb, et al.
Transplantation|March 1, 1993
What role for 15-deoxyspergualin in enhancing engraftment of unrelated, histoincompatible canine marrow grafts and preventing graft-versus-host disease?R F Raff, R Storb, T Graham, et al.
Blood|September 1, 1981
Treatment of non-Hodgkin's lymphoma with marrow transplantation in identical twinsF R Appelbaum, A Fefer, M A Cheever, et al.
Bone Marrow Transplantation|March 1, 1993
Consequences of cryopreserving first remission autologous marrow for use after relapse in patients with acute myeloid leukemiaK Schiffman, R Clift, F R Appelbaum, et al.
Blood|April 15, 1993
A prospective randomized comparison of total body irradiation-etoposide versus busulfan-cyclophosphamide as preparatory regimens for bone marrow transplantation in patients with leukemia who were not in first remission: a Southwest Oncology Group studyK G Blume, K J Kopecky, J P Henslee-Downey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Conditioning regimen-dependent disposition of cyclophosphamide and hydroxycyclophosphamide in human marrow transplantation patientsJ T Slattery, T F Kalhorn, G B McDonald, et al.
Bone Marrow Transplantation|September 1, 1996
Syngeneic marrow transplantation in patients with multiple myelomaW I Bensinger, T Demirer, C D Buckner, et al.
Blood|June 1, 1994
Cyclophosphamide plus ATG conditioning is insufficient for sustained hematopoietic reconstitution in patients with severe aplastic anemia transplanted with marrow from HLA-A, B, DRB matched unrelated donorsH J Deeg, C Anasetti, E Petersdorf, et al.
Pageof 49